Loading insider details...
Beta
Latest Form 4 (Jul 18, 2026): Grant/Award of 4,406 shares.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 18, 2026 | Keenova Therapeutics plc | Grant/Award | 4,406 | n/a |
| Jul 2, 2026 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 32,000 | n/a |
| Jun 10, 2026 | Prelude Therapeutics Inc (PRLD) | Grant/Award | 38,000 | n/a |
| Jun 4, 2026 | Keenova Therapeutics plc | Exercise/Conversion | 4,882 | n/a |
| May 22, 2026 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 67,000 | n/a |
| Feb 26, 2026 | Keenova Therapeutics plc | Grant/Award | 3,984 | n/a |
| Oct 20, 2025 | Prelude Therapeutics Inc (PRLD) | Grant/Award | 76,000 | n/a |
| Jul 2, 2025 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 67,000 | n/a |
| Jun 30, 2025 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 36,000 | n/a |
| Jun 18, 2024 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 30,000 | n/a |